FGF19 and cholestasis: Fibroblast growth factor 19 (FGF19) analogue and inhibitors of the gut bile acid uptake transporter apical sodium-dependent bile acid transporter (ASBT) have been investigated as potential new therapeutics for cholestasis [8,9,10,11,12].